The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis Mohamed A. M. Ali Review Article 03 March 2021 Pages: 795 - 825
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study Gulcin Sahingoz ErdalOzlem PolatDeniz Tural Original Article 24 January 2021 Pages: 826 - 834
Preoperative predictors of dysphagia after transoral surgery Kazunori FujiwaraKenkichiro TairaHiromi Takeuchi Original Article Open access 18 January 2021 Pages: 835 - 840
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations Gee-Chen ChangDavid Chi-Leung LamKeunchil Park Original Article Open access 30 March 2021 Pages: 841 - 850
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients Shoko KawaiKageaki WatanabeYukio Hosomi Original Article 03 March 2021 Pages: 851 - 857
Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis Shunji EndoKazuhiro NishikawaTomio Ueno Original Article 17 February 2021 Pages: 858 - 866
The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database Shuangxi LiJacopo DesiderioAmilcare Parisi Original Article 31 March 2021 Pages: 867 - 874
A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer Jun HigashijimaTakuya TokunagaMitsuo Shimada Original Article 23 January 2021 Pages: 875 - 882
Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis Nobuaki HoshinoRyuhei AoyamaKoya Hida Original Article 09 January 2021 Pages: 883 - 892
Improved oncologic outcomes with increase of laparoscopic surgery in modified complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer: results of 1191 consecutive patients during a 10-year period: a retrospective cohort study Tetsuro TominagaTomohiro YamaguchiTsuyoshi Konishi Original Article 22 January 2021 Pages: 893 - 902
The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients Kosuke MimaNobutomo MiyanariHideo Baba Original Article 28 January 2021 Pages: 903 - 912
Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes Zachary Zihui YongJolene Si Min WongGrace Hwei Ching Tan Original Article Open access 02 February 2021 Pages: 913 - 921
Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients Takayuki TokunagaMotohiko TanakaYasuhito Tanaka Original Article 17 March 2021 Pages: 922 - 932
Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma Yong WangZhongran ManQing Pang Original Article 25 February 2021 Pages: 933 - 940
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study Taiga OtsukaTsuyoshi ShirakawaNorio Ureshino Original Article 23 January 2021 Pages: 941 - 950
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study Taiga OtsukaTsuyoshi ShirakawaNorio Ureshino Correction 03 March 2021 Pages: 951 - 953
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study Taigo KatoAkira NagaharaMotohide Uemura Original Article 20 January 2021 Pages: 954 - 961
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma Giuseppe RosielloAngela PecoraroPierre I. Karakiewicz Original Article 30 January 2021 Pages: 962 - 970
Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study Shinichi TogamiHiroaki KobayashiDaisuke Aoki Original Article 25 March 2021 Pages: 971 - 979
A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer Akira KawataAyumi TaguchiTomoyuki Fujii Original Article 21 January 2021 Pages: 980 - 985
Introduction of rectosigmoid colectomy improves survival outcomes in early-stage ovarian cancer patients Shinichi TateKyoko NishikimiMakio Shozu Original Article 07 March 2021 Pages: 986 - 994
Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer Yutaka IwagoiTakeshi MotoharaHidetaka Katabuchi Original Article Open access 29 January 2021 Pages: 995 - 1004
Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real‑world clinical practice: a multicentre retrospective clinical study Nobuhiro HanaiYasushi ShimizuAkihiro Homma Correction Open access 10 April 2021 Pages: 1005 - 1006
Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan Kuniko SunamiYoichi NaitoTakayuki Yoshino Correction 30 March 2021 Pages: 1007 - 1007
